SANA
Sana Biotechnology Inc
2.80$
-4.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 44.3% | 37.8% | 47.1% | 42.6% | 37.6% | 32.1% | 25.3% | 22.8% | 37.1% | 35.7% | 29.9% | 39.5% | |
| 26.7% | 23.6% | 26.0% | 21.8% | 22.7% | 25.5% | 21.6% | 19.7% | 23.7% | 17.2% | 22.4% | 13.2% | |
| 42.5% | 36.3% | 45.7% | 40.7% | 35.6% | 30.4% | 23.5% | 20.1% | 35.1% | 33.2% | 27.1% | 37.2% | |
| 22.3% | 24.9% | 20.6% | 22.7% | 25.1% | 28.1% | 31.6% | 38.9% | 32.3% | 33.7% | 37.6% | 32.6% | |
| 9.4% | 10.5% | 8.7% | 9.6% | 10.6% | 11.8% | 13.3% | 16.4% | 13.6% | 14.2% | 15.8% | 13.7% | |
| 42.1% | 49.1% | 44.9% | 45.1% | 47.7% | 50.0% | 53.1% | 66.1% | 55.1% | 61.4% | 68.1% | 64.2% | |
| 10.6% | 11.4% | 7.8% | 8.2% | 8.4% | 9.1% | 7.4% | 9.2% | 8.2% | 18.9% | 23.1% | 28.7% | |
| 2.1% | 2.3% | 1.9% | 1.6% | 1.9% | 2.5% | 2.9% | 3.8% | 3.4% | 3.6% | 4.0% | 3.4% | |
| 1.6% | 0.7% | 0.9% | 0.6% | 0.5% | 1.0% | 0.2% | 0.6% | 0.4% | 0.4% | 0.6% | 0.3% | |
| 57.9% | 50.9% | 55.1% | 54.9% | 52.3% | 50.0% | 46.9% | 33.9% | 44.9% | 38.6% | 31.9% | 35.8% | |
| -198.0% | -236.7% | -212.2% | -241.8% | -278.1% | -320.3% | -371.3% | -483.4% | -411.1% | -443.5% | -507.6% | -454.2% | |
| 31.7% | 34.9% | 31.9% | 37.9% | 42.1% | 47.2% | 53.3% | 65.9% | 59.8% | 60.7% | 74.1% | 68.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.